{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:09:33Z","timestamp":1790179773729,"version":"4.1.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Familial hypocalciuric hypercalcemia type 1 (FHH-1) defines an autosomal dominant disease, related to mutations in the CASR gene, with mild hypercalcemia in most cases. Cases of FHH-1 with a short QT interval have not been reported to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Three family members presented with FHH-1 and short QT interval (&amp;lt;360 ms), a condition that could lead to cardiac arrhythmias, and the effects of cinacalcet, an allosteric modulator of the CaSR, in rectifying the abnormal sensitivity of the mutant CaSR and in correcting the short QT interval were determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CASR mutational analysis was performed by next-generation sequencing and functional consequences of the identified CaSR variant (p.Ile555Thr), and effects of cinacalcet were assessed in HEK293 cells expressing wild-type and variant CaSRs. A cinacalcet test consisting of administration of 30 mg cinacalcet (8 Am) followed by measurement of serum calcium, phosphate, and parathyroid hormone every two hours for 8 hours. An electrocardiogram was performed 8 hours after cinacalcet administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The CaSR variant (p.Ile555Thr) was confirmed in all 3 FHH-1 patients and was shown to be associated with a loss of function that was ameliorated by cinacalcet. Cinacalcet decreased parathyroid hormone by &amp;gt;50% within two hours, and decreases in serum calcium and increases in serum phosphate occurred within 8 hours, with rectification of the QT interval, which remained normal after 3 months of cinacalcet treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results indicate that FHH-1 patients should be assessed for a short QT interval and a cinacalcet test used to select patients who are likely to benefit from this treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad494","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T16:33:39Z","timestamp":1692290019000},"page":"549-556","source":"Crossref","is-referenced-by-count":6,"title":["Cinacalcet Reverses Short QT Interval in Familial Hypocalciuric Hypercalcemia Type 1"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-0030","authenticated-orcid":false,"given":"Thomas","family":"Cuny","sequence":"first","affiliation":[{"name":"Aix Marseille University, APHM, Marseille Medical Genetics, Inserm U1251, H\u00f4pital de la Conception, Service d'Endocrinologie , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-9569","authenticated-orcid":false,"given":"Pauline","family":"Romanet","sequence":"additional","affiliation":[{"name":"Aix Marseille University, APHM, Marseille Medical Genetics, Inserm U1251, H\u00f4pital de la Conception, Laboratoire de Biochimie et Biologie mol\u00e9culaire , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Goldsworthy","sequence":"additional","affiliation":[{"name":"Nuffield Department of Surgical Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Gu\u00e9rin","sequence":"additional","affiliation":[{"name":"Aix Marseille University, APHM, H\u00f4pital de la Conception, Service de Chirurgie endocrinienne , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wilkin","sequence":"additional","affiliation":[{"name":"Aix Marseille University, APHM, H\u00f4pital de la Timone, Service de Cardiologie , Marseille \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5580-0588","authenticated-orcid":false,"given":"Philippe","family":"Roche","sequence":"additional","affiliation":[{"name":"Integrative Structural & Chemical Biology & HiTS Platform, Cancer Research Centre of Marseille, CNRS UMR7258 , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-3415","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Sebag","sequence":"additional","affiliation":[{"name":"Aix Marseille University, APHM, H\u00f4pital de la Conception, Service de Chirurgie endocrinienne , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E","family":"van Summeren","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8616-0205","authenticated-orcid":false,"given":"Mark","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A","family":"Howles","sequence":"additional","affiliation":[{"name":"Nuffield Department of Surgical Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1534-3845","authenticated-orcid":false,"given":"Jean-Claude","family":"Deharo","sequence":"additional","affiliation":[{"name":"Aix Marseille University, APHM, H\u00f4pital de la Timone, Service de Cardiologie , Marseille \u00a0","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-3220","authenticated-orcid":false,"given":"Rajesh V","family":"Thakker","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford , Oxford ,","place":["UK"]},{"name":"National Institute for Health Research Oxford Biomedical Research Centre , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-7600","authenticated-orcid":false,"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"issue":"7","key":"2026092311554225300_dgad494-B1","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"issue":"1","key":"2026092311554225300_dgad494-B2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"issue":"14","key":"2026092311554225300_dgad494-B3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM198010023031409","article-title":"Familial hypocalciuric hypercalcemia","volume":"303","author":"Marx","year":"1980","journal-title":"N Engl J Med"},{"issue":"2","key":"2026092311554225300_dgad494-B4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12020-021-02909-5","article-title":"Familial hypocalciuric hypercalcemia: the challenge of diagnosis","volume":"75","author":"Lasbleiz","year":"2021","journal-title":"Endocrine"},{"issue":"4","key":"2026092311554225300_dgad494-B5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCEP.109.921056","article-title":"Short QT syndrome: from bench to bedside","volume":"3","author":"Patel","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"2026092311554225300_dgad494-B6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.clinthera.2005.11.015","article-title":"Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism","volume":"27","author":"Dong","year":"2005","journal-title":"Clin Ther"},{"issue":"7","key":"2026092311554225300_dgad494-B7","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/jc.2015-1518","article-title":"Cinacalcet treatment in an adolescent with concurrent 22q11.2 deletion syndrome and familial hypocalciuric hypercalcemia type 3 caused by AP2S1 mutation","volume":"100","author":"Tenhola","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2026092311554225300_dgad494-B8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMc1511646","article-title":"Cinacalcet for symptomatic hypercalcemia caused by AP2S1 mutations","volume":"374","author":"Howles","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"2026092311554225300_dgad494-B9","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2017-01606","article-title":"Calcimimetic use in familial hypocalciuric hypercalcemia-a perspective in endocrinology","volume":"102","author":"Marx","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026092311554225300_dgad494-B10","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","article-title":"Genetics in endocrinology: gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts","volume":"174","author":"Mayr","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026092311554225300_dgad494-B11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.0000085071.28695.C4","article-title":"Short QT syndrome: a familial cause of sudden death","volume":"108","author":"Gaita","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"2026092311554225300_dgad494-B12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11154-021-09694-6","article-title":"The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies","volume":"23","author":"Chandran","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"2026092311554225300_dgad494-B13","doi-asserted-by":"publisher","author":"Cuny","DOI":"10.6084\/m9.figshare.23692089"},{"key":"2026092311554225300_dgad494-B14","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/978-3-030-12457-1_41","article-title":"Sensing extracellular calcium\u2014an insight into the structure and function of the calcium-sensing receptor (CaSR)","volume":"1131","author":"Chavez-Abiega","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"2026092311554225300_dgad494-B15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41422-021-00474-0","article-title":"Structural mechanism of cooperative activation of the human calcium-sensing receptor by Ca2+ ions and L-tryptophan","volume":"31","author":"Ling","year":"2021","journal-title":"Cell Res"},{"key":"2026092311554225300_dgad494-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-0366-5_1","article-title":"Protein structure modeling with MODELLER","volume":"1137","author":"Webb","year":"2014","journal-title":"Methods Mol. Biol"},{"issue":"5","key":"2026092311554225300_dgad494-B17","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026092311554225300_dgad494-B18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1687-9856-2012-13","article-title":"A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia","volume":"2012","author":"Tonyushkina","year":"2012","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1","key":"2026092311554225300_dgad494-B19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0129","article-title":"Novel mutations associated with inherited human calcium-sensing receptor disorders: a clinical genetic study","volume":"180","author":"Garc\u00eda-Casta\u00f1o","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026092311554225300_dgad494-B20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cen.14211","article-title":"Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: a multicentre study of 77 adult patients","volume":"93","author":"Mouly","year":"2020","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"35","key":"2026092311554225300_dgad494-B21","doi-asserted-by":"crossref","first-page":"e21940","DOI":"10.1097\/MD.0000000000021940","article-title":"Familial hypocalciuric hypercalcemia caused by homozygous CaSR gene mutation: a case report of a family","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"2026092311554225300_dgad494-B22","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2007-0322","article-title":"Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population","volume":"92","author":"Nissen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026092311554225300_dgad494-B23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7861\/clinmedicine.17-3-270","article-title":"Hypercalcaemia\u2014presentation and management","volume":"17","author":"Turner","year":"2017","journal-title":"Clin. Med"},{"issue":"6868","key":"2026092311554225300_dgad494-B24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"2","key":"2026092311554225300_dgad494-B25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/clc.4960040205","article-title":"The QT interval in clinical hypercalcemia","volume":"4","author":"Wortsman","year":"1981","journal-title":"Clin Cardiol"},{"key":"2026092311554225300_dgad494-B26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vph.2018.02.007","article-title":"Calcium sensing receptor expression and signalling in cardiovascular physiology and disease","volume":"107","author":"Schreckenberg","year":"2018","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"2026092311554225300_dgad494-B27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(91)90116-8","article-title":"Ischemia- and reperfusion-induced arrhythmias are prevented by putrescine","volume":"194","author":"Tagliavini","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"2026092311554225300_dgad494-B28","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3390\/jcm11092595","article-title":"Disorders of the calcium sensing signaling pathway: from familial hypocalciuric hypercalcemia (FHH) to life threatening conditions in infancy","volume":"11","author":"H\u00f6ppner","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"2026092311554225300_dgad494-B29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00424-014-1498-y","article-title":"Mechanisms by which calcium receptor stimulation modifies electromechanical coupling in isolated ventricular cardiomyocytes","volume":"467","author":"Schreckenberg","year":"2015","journal-title":"Pflugers Arch"},{"issue":"6","key":"2026092311554225300_dgad494-B30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","article-title":"Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population","volume":"106","author":"Dershem","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2026092311554225300_dgad494-B31","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J. Bone Miner. Res"},{"issue":"2","key":"2026092311554225300_dgad494-B32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/eci.12038","article-title":"Arrhythmias in primary hyperparathyroidism evaluated by exercise test","volume":"43","author":"Pepe","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2026092311554225300_dgad494-B33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-17-0948","article-title":"Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring","volume":"179","author":"Pepe","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026092311554225300_dgad494-B34","doi-asserted-by":"crossref","first-page":"e1689","DOI":"10.1210\/clinem\/dgab820","article-title":"Primary hyperparathyroidism is associated with shorter QTc intervals, but not arrhythmia","volume":"107","author":"Stewart","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 3","key":"2026092311554225300_dgad494-B35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1258\/acb.2010.010139","article-title":"Four cases of autosomal dominant hypocalcaemia with hypercalciuria including two with novel mutations in the calcium-sensing receptor gene","volume":"48","author":"Schouten","year":"2011","journal-title":"Ann Clin Biochem"},{"issue":"7","key":"2026092311554225300_dgad494-B36","first-page":"520","article-title":"Effects of cinacalcet treatment on QT interval in hemodialysis patients","volume":"16","author":"Temiz","year":"2016","journal-title":"Anatol J Cardiol"},{"issue":"1","key":"2026092311554225300_dgad494-B37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jbmr.3241","article-title":"Cinacalcet rectifies hypercalcemia in a patient with familial hypocalciuric hypercalcemia type 2 (FHH2) caused by a germline loss-of-function G\u03b111 mutation","volume":"33","author":"Gorvin","year":"2018","journal-title":"J. Bone Miner. Res"},{"issue":"20","key":"2026092311554225300_dgad494-B38","doi-asserted-by":"crossref","first-page":"e96540","DOI":"10.1172\/jci.insight.96540","article-title":"Cinacalcet corrects hypercalcemia in mice with an inactivating G\u03b111 mutation","volume":"2","author":"Howles","year":"2017","journal-title":"JCI insight"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad494\/51276002\/dgad494.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/2\/549\/55525251\/dgad494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/2\/549\/55525251\/dgad494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:55:51Z","timestamp":1790178951000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/2\/549\/7246602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2024,1,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad494","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,8,21]]}}}